AI is revolutionizing biology in unprecedented ways. That’s why we’re partnering with Stef van Grieken and the Cradle team on their $73M Series B. 🧬 Cradle is harnessing AI to transform protein engineering, which helps scientists design new therapies and sustainable products faster and more efficiently. The platform enables companies like Johnson & Johnson Innovative Medicine and Novo Nordisk to speed up R&D by up to 12x. We’re partnering with them to accelerate AI-powered bioengineering and its impact on global challenges in healthcare and sustainability. More on why we believe here: https://lnkd.in/gkYzGxxH
IVP
Venture Capital and Private Equity Principals
Menlo Park, CA 20,918 followers
Undaunted on the path to extraordinary outcomes. We turn breakout companies into enduring market leaders.
About us
Like you, we are undaunted on the path to extraordinary outcomes. We grow breakout companies into enduring market leaders. IVP’s 40-year track record of driving growth includes partnering with over 400 companies, resulting in over 130 IPOs. Our low-ego, hands-on approach has served companies like Amplitude, Coinbase, Crowdstrike, Datadog, Discord, Klarna, Slack, Snap, and Twitter in innumerable ways. We are unafraid of the challenges and hard work that come with becoming the dominant player. Our proven system bolsters key functions, including those that are sometimes overlooked, and our partners serve as trusted allies to CEOs seeking to realize their company’s full potential. For more information visit ivp.com.
- Website
-
http://www.ivp.com
External link for IVP
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 51-200 employees
- Headquarters
- Menlo Park, CA
- Type
- Privately Held
- Founded
- 1980
- Specialties
- venture capital, later-stage venture capital, growth equity, and investing in growth
Locations
-
Primary
3000 Sand Hill Road
Building 2, Suite 250
Menlo Park, CA 94025, US
-
747 Front Street
Suite 100
San Francisco, CA 94111, US
Employees at IVP
Updates
-
IVP reposted this
🧲 Slush has an undeniable magnetism, and the side events are a big reason why. We always look forward to our annual dinner with our friends at IVP, where we share portfolio companies and values. This year the central vibe was optimism despite all odds. 🍽️ We gathered at Robusto in Helsinki for connections and conversations. Thanks to our growing ecosystem of startups, investors, LPs, journalists, and tech supporters for joining us! 👀 We look forward to the next memorable visit. Enjoy a glimpse of the evening below. With: Dr. Christian Nagel, Paul Klemm, Tim Rehder, Vincenzo Narciso, Elle Muller, Eric Liaw, & many more #Slush24 #IVP #EBVCteam #Europe #Optimism #TechEcosystem #Helsinki #VC
-
Each winter, European tech and venture leaders come together in Helsinki to discuss the future of the industry. From the Slush show floor, IVP’s Eric Liaw spoke with CNBC about trends in European tech, AI and the public markets. He shared insights on standout companies like Perplexity, DeepL and Abridge, as well as the scale required for new entrants to succeed in public markets. Catch Eric’s perspective on the state of tech in Europe: https://lnkd.in/gS74uZ_e
-
Leading a remarkable company means envisioning the future while driving results now. At our CEO gathering, Undaunted 2024, CEOs swapped hard-earned wisdom on building product, team and the future. Here is a selection of what was shared: “Work backward from the future you want to create,” declared Yamini Rangan. With AI accelerating product development, annual planning is too slow—teams need to operate in 3-6 month sprints to stay ahead. “As a founder-CEO, you have the unique ability to navigate all levels of the company. Put your ear to the ground and stay connected to your team.” George Kurtz encouraged CEOs to leverage their unique position to stay in touch with every layer of their organization. “If you’ve got 5 gears, what’s the point of being in 2nd?” asked Larry Fitzgerald Jr., who pushes to the highest level of performance, both in business and on the field. “High alignment brings high autonomy.” Liz H. fosters cohesion at Ring by prioritizing 1:1s, monthly town halls and weekly topics meetings. “Product market fit is dead in this environment.” Bipul Sinha believes finding PMF is no longer a one-time achievement but a constant pursuit, to be reevaluated every 6-9 months. “Build startups within your startup,” Jyoti Bansal insists that each new product be run like a seed-stage startup with a mini CEO, allocating engineering resources as it reaches new benchmarks, just like a Series A or B investor would. “Talent is your ONLY differentiator” and should always be your #1 operating priority. Emilie Choi said she and Brian still approve every new Coinbase hire. “Two things are true as CEO: 1. You’re going to live in a constant state of conflict AND 2. It’s important along the way to acknowledge the moments where you internalize just how special this journey is.” David McJannet recommends savoring the moments that go well. “Just make the call.” Kevin Weil shared that OpenAI has a refreshing lack of respect for the org traditional chart. Instead of asking someone who will ask someone to do it, they get it done regardless. Strength for CEOs means something different to each individual. Strength = embracing discomfort, vulnerability, creativity, authenticity, the 5th gear, NOW and so much more. Below are a few moments that capture Undaunted 2024. CrowdStrike Rubrik HubSpot Harness HashiCorp
-
+9
-
At IVP, we partner with consequential companies that are reshaping their industries—and Numeric is doing exactly that. By leveraging AI to automate the accounting close process, Numeric is not only solving a painful, time-consuming problem but also unlocking real-time financial insights that businesses need to stay ahead. 🎯 With explosive growth and an impressive roster of customers like OpenAI, Brex, and Plaid, Numeric is poised to fix much more than just the monthly close. Here’s why we’re partnering with Parker Gilbert, Andrew Bihl, Anthony Alvernaz, and the entire team on their Series A. https://lnkd.in/ecV5D6vR
-
Last week, we hosted a Federal Sales Workshop designed to help high-growth companies enhance their fed sales strategies and navigate selling to the government. Here are some key takeaways from the day: 🔑 Passion Matters: Howard Levenson stressed that success in Federal Sales comes from a deep connection to the mission—serving the public and driving impact. The long sales cycle demands more than financial goals; it requires real passion. 📊 Value Beyond ROI: Ret. General Richard Clarke noted that in federal sales, success often comes from showing how your solution frees up essential resources—like personnel—for critical tasks rather than simply focusing on traditional ROI. 📌 Unique Federal Sales Challenges: It's essential for leaders to understand: • Longer sales cycles • Complex compliance issues • Security clearance requirements • The federal fiscal year starting on 10/1 👥 What to Look for in Federal Sales Leaders: • 5+ years of federal sales experience • Strong sector relationships • Security clearance • Startup experience in building federal business A big thank you to our expert speakers, including Howard Levenson, Ret. General Richard Clarke, Melissa Johnson, Kristyn Jones, Samuel Riehn, MBA, Craig Abod, George Hoyem, Barry Leffew, and Mike Daniels.
-
IVP reposted this
𝗡𝗲𝘄 𝗪𝗵𝗶𝘁𝗲𝗽𝗮𝗽𝗲𝗿: 𝗧𝗵𝗶𝘀 𝗶𝘀 𝗘𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲-𝗴𝗿𝗮𝗱𝗲 𝗔𝗜. Read our latest whitepaper, authored by Abridge CSO/CTO Zachary Lipton, Davis Liang, and Michael Oberst, detailing the deep science behind our technology. Our process for evaluation and benchmarking integrates clinician expertise and real-world data, and is trusted by some of the largest healthcare systems in the country. Read the full whitepaper here: https://lnkd.in/edBFAXdU
-
IVP reposted this
👥Patients 👨⚕️Providers 🤝Payers 💊Pharma At IVP, AI is accelerating all four of the health segments we track, creating new value, efficiencies and true innovation. Along with my colleagues Cynthia and Somesh, we mapped out the most exciting health companies breaking out due to AI. I’m optimistic about how AI will continue to transform health. Links to the companies and the full post in the comments. What companies or tech themes would you add to our research?
-
IVP reposted this
The speed of innovation in health care is accelerating, with AI creating new possibilities in research, delivery and coordination. We’ve seen AI-born leaps in physician efficiency from Abridge, patient matching with Lyra Health, personalized health plans from Hello Heart and data discovery with H1, among many others. Members of the IVP team (Yuri Lee, Cynthia Lai and me) issued our first Health AI report today, spotlighting some of the pioneers in health AI today. We’re excited to track these companies and their momentum as the health AI landscape evolves!
Generative AI has the potential to revolutionize health care. In an industry overflowing with data and tasks that are time-consuming and expensive, AI offers a powerful solution to automate workflows, create new insights, and improve the quality of care. But not all health AI companies are created equally. Health care is a double-edged sword—tough for companies to break into, but incredibly sticky once they do. That’s why we focus on health AI companies that practitioners actually use—those with a clear technological edge and a unique go-to-market strategy. While this is far from complete, here are some of the companies creating tangible value across patients, providers, pharmaceutical companies, and payers right now: 🏥 For patients: Improving care and trust 👨⚕️ For providers: Reducing the administrative burden 💊 For pharma: Accelerating drug discovery 📋 For payers: Navigating complex regulations Kudos to all the companies recognized as health AI pioneers. Check out the full overview developed by Yuri, Cynthia and Somesh, through the link in the comments.
-
IVP reposted this
AI is rapidly transforming health care—streamlining workflows, driving drug innovation, and elevating the quality of care. To stay ahead of these advancements, Somesh, Yuri, and I recently engaged with healthcare leaders and customers across the patient, provider, payer, and pharma ecosystems to create IVP's Health AI 35—a look into the most promising AI companies in health care today. Below are a few key insights we gathered from industry experts, highlighting where AI is making the biggest impact. The future of AI in health care is incredibly promising, and we’re excited to see how these technologies will continue to shape the industry: “Clinicians today face tremendous pressure to see a growing number of patients with fewer resources. We’re working with innovative health systems to restore humanity to the health care experience. The remarkable outcomes and resoundingly positive feedback from clinicians underscore the profound impact of generative AI on the future of medicine. By alleviating cognitive load and creating space for more meaningful patient interactions, we will improve the lives of clinicians today.” - Dr. Shivdev Rao, Abridge “Generative AI has the opportunity to vastly accelerate the time needed to discover and develop therapeutics such as antibodies, vaccines and peptides to cure many more diseases. Similarly to how generative image models allow creators to come up with novel pictures and videos, scientists can now generate improved versions of molecules or come up with completely new-to-nature molecules to solve harder problems.” - Stef van Grieken, Cradle “With AI, we can bring the expertise of millions of providers to a single customer, rather than simply allowing one provider to reach more individuals. The potential for this level of personalized care is what we are the most excited about in this space.” - hims & hers "AI has the potential to make health care more human – a concept that has captured my and many others' imaginations. AI can also make it simpler to access high-quality care - with quality measured based on outcomes that matter to patients. Health care delivery is in itself incredibly intimate and human and we are at the frontier of applications of AI - we should be humble about its benefits and limitations. AI is a complement, not substitute, and can always improve - as such applications benefit from appropriate human supervision in the day-to-day workflows." Azalea Kim MD MBA MPA, Accompany Health "AI will create new opportunities to find correlations across massive datasets and truly understand how to drive improved health outcomes at scale. From personal, tailored medical plans to better utilization of real-world data in medical decision making, AI makes it easier for individuals to achieve better health through data insights." - Consumer health leader at major tech company
Generative AI has the potential to revolutionize health care. In an industry overflowing with data and tasks that are time-consuming and expensive, AI offers a powerful solution to automate workflows, create new insights, and improve the quality of care. But not all health AI companies are created equally. Health care is a double-edged sword—tough for companies to break into, but incredibly sticky once they do. That’s why we focus on health AI companies that practitioners actually use—those with a clear technological edge and a unique go-to-market strategy. While this is far from complete, here are some of the companies creating tangible value across patients, providers, pharmaceutical companies, and payers right now: 🏥 For patients: Improving care and trust 👨⚕️ For providers: Reducing the administrative burden 💊 For pharma: Accelerating drug discovery 📋 For payers: Navigating complex regulations Kudos to all the companies recognized as health AI pioneers. Check out the full overview developed by Yuri, Cynthia and Somesh, through the link in the comments.